STAA News and Press, STAAR Surgical Company From 12/19/25

2025-12-19 12:06:53 ET More on STAAR Surgical STAAR Surgical: Alcon Raises Its Bid, But Obstacles Remain STAAR Surgical gains as proxy adviser ISS supports revised Alcon deal STAAR Surgical falls as proxy adviser recommends against revised Alcon deal (update) ...

STAAR Special Meeting of Stockholders Adjourned to January 6, 2026 STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL) today announced that Alcon (SIX/NYSE: ALC) has exercised its right under the Alcon merger agreement to require STAAR ...

Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc. PR Newswire Expresses Disappointment in the Board's and Management's Continued Pursuit of Ill-advised Deal CHARLOTTE, N.C. , Dec. 17, 2025 /PRNewswire/ -- Defender Capital (...

Expresses Confidence in STAAR’s Future and the Opportunity for Significant Value Creation Believes STAAR is Worth at Least $50 Per Share If the Company Is Run in Best Interest of Shareholders Broadwood Partners, L.P. and its affiliates (collectively, “Broad...

Broadwood Has Consistently Misled STAAR Stockholders About Takeover Interest in STAAR In Order to Derail the Alcon Merger STAAR Urges Stockholders to Vote “FOR” the Alcon Transaction on WHITE Proxy Card TODAY STAAR Surgical Company (NASDAQ: STAA), the global lead...

Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), today released the following letter to ...

Increased Alcon Merger Price of $30.75 per Share is an Attractive Outcome for STAAR Stockholders STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses (EVO ICL™) for vision correction, today reporte...

ISS Says It Would Not Be “Unreasonable for a Shareholder to Remain Opposed” to the Deal Broadwood Encourages Shareholders to Follow the Recommendations of Proxy Advisory Firms Glass Lewis and Egan-Jones, Both of Whom Recommend Shareholders Vote “ AGAINST ...

2025-12-15 19:30:55 ET More on STAAR Surgical STAAR Surgical: Alcon Raises Its Bid, But Obstacles Remain STAAR Surgical falls as proxy adviser recommends against revised Alcon deal (update) STAAR Surgical holder Yunqi Capital still against sale to Alcon Seeki...

STAAR Urges Stockholders to Vote “FOR” Alcon Merger on the WHITE Proxy Card TODAY STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses (EVO ICL™) for vision co...